Bryony Simmons

6.2k total citations · 2 hit papers
41 papers, 3.4k citations indexed

About

Bryony Simmons is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Bryony Simmons has authored 41 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Bryony Simmons's work include HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers) and Hepatitis C virus research (9 papers). Bryony Simmons is often cited by papers focused on HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (11 papers) and Hepatitis C virus research (9 papers). Bryony Simmons collaborates with scholars based in United Kingdom, United States and South Africa. Bryony Simmons's co-authors include Anne H. Fossel, Jeffrey N. Katz, Lawren H. Daltroy, Douglas W. Levine, Mark J. Koris, Andrew Hill, Graham Cooke, Joseph Fortunak, Richard D Riley and Nathan Ford and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Bryony Simmons

40 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome.

1993 1.5k citations Bryony Simmons et al. profile →
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

2019 442 citations François Venter, Michelle Moorhouse et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryony Simmons United Kingdom	21	1.5k	1.4k	841	747	662	41	3.4k
Piergiorgio Duca Italy	27	882 0.6×	328 0.2×	212 0.3×	1.1k 1.5×	455 0.7×	99	2.9k
Ana Royuela Spain	29	617 0.4×	117 0.1×	218 0.3×	404 0.5×	186 0.3×	147	3.1k
David L. Hom United States	30	494 0.3×	242 0.2×	1.4k 1.7×	1.1k 1.4×	26 0.0×	50	2.9k
Karina M. Berg United States	20	80 0.1×	797 0.6×	754 0.9×	616 0.8×	66 0.1×	41	2.4k
Colleen Hadigan United States	44	778 0.5×	75 0.1×	2.8k 3.3×	1.2k 1.6×	372 0.6×	131	6.8k
Nina Kohn United States	24	510 0.3×	113 0.1×	198 0.2×	603 0.8×	41 0.1×	136	2.8k
A Lafuma France	25	413 0.3×	585 0.4×	114 0.1×	527 0.7×	75 0.1×	131	2.4k
Sasivimol Rattanasiri Thailand	26	404 0.3×	55 0.0×	310 0.4×	488 0.7×	83 0.1×	118	2.1k
David Lora Spain	26	359 0.2×	136 0.1×	182 0.2×	676 0.9×	55 0.1×	148	2.5k
Bernadette Zakher United States	21	89 0.1×	205 0.1×	100 0.1×	489 0.7×	212 0.3×	45	2.2k

Countries citing papers authored by Bryony Simmons

Since Specialization

Citations

This map shows the geographic impact of Bryony Simmons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryony Simmons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryony Simmons more than expected).

Fields of papers citing papers by Bryony Simmons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryony Simmons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryony Simmons. The network helps show where Bryony Simmons may publish in the future.

Co-authorship network of co-authors of Bryony Simmons

This figure shows the co-authorship network connecting the top 25 collaborators of Bryony Simmons. A scholar is included among the top collaborators of Bryony Simmons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryony Simmons. Bryony Simmons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hill, Andrew, Simiso Sokhela, Bryony Simmons, et al.. (2024). Low CD4 counts predict excessive weight gains during first-line treatment for HIV. Journal of Antimicrobial Chemotherapy. 79(9). 2369–2378. 4 indexed citations

Simmons, Bryony, Elisa Sicuri, Jane Y. Carter, et al.. (2024). Defining a malaria diagnostic pathway from innovation to adoption: Stakeholder perspectives on data and evidence gaps. SHILAP Revista de lepidopterología. 4(5). e0002957–e0002957.

Griesel, Rulan, Ying Zhao, Bryony Simmons, et al.. (2023). Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial. The Lancet HIV. 10(7). e433–e441. 24 indexed citations

Zhao, Ying, Rulan Griesel, Bryony Simmons, et al.. (2023). Initial Supplementary Dose of Dolutegravir in Second-Line Antiretroviral Therapy: A Noncomparative, Double-Blind, Randomized Placebo-Controlled Trial. Clinical Infectious Diseases. 76(10). 1832–1840. 4 indexed citations

Sokhela, Simiso, Andrew Hill, Bryony Simmons, et al.. (2022). Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection. Journal of Antimicrobial Chemotherapy. 77(10). 2706–2712. 6 indexed citations

Kiemdé, François, Halidou Tinto, Jane Y. Carter, et al.. (2022). Phase 3 evaluation of an innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in sub-Saharan Africa (DIAGMAL). PLoS ONE. 17(9). e0272847–e0272847. 1 indexed citations

Simmons, Bryony, Koya Ariyoshi, Norio Ohmagari, et al.. (2021). Progress towards antibiotic use targets in eight high-income countries. Bulletin of the World Health Organization. 99(8). 550–561. 15 indexed citations

Siedner, Mark J., Michelle Moorhouse, Bryony Simmons, et al.. (2020). Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase. Nature Communications. 11(1). 5922–5922. 59 indexed citations

Jones, Christopher R., Barnaby Flower, Ella Barber, Bryony Simmons, & Graham Cooke. (2019). Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis. SHILAP Revista de lepidopterología. 4. 132–132. 9 indexed citations

10.

Venter, François, Michelle Moorhouse, Simiso Sokhela, et al.. (2019). Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. New England Journal of Medicine. 381(9). 803–815. 442 indexed citations breakdown →

11.

Brown, Darren A., Bryony Simmons, Marta Boffito, et al.. (2019). Evaluation of the psychometric properties of the HIV Disability Questionnaire among adults living with HIV in the United Kingdom: A cross-sectional self-report measurement study. PLoS ONE. 14(7). e0213222–e0213222. 15 indexed citations

12.

Maio, Michele, Lev Demidov, Mario Mandalà, et al.. (2017). BRIM8: a randomized, double-blind, placebo-controlled study of adjuvant vemurafenib in patients (pts) with completely resected, BRAFV600+ melanoma at high risk for recurrence. Annals of Oncology. 28. v631–v632. 6 indexed citations

13.

Simmons, Bryony, Jean Damascène Makuza, Aimable Mbituyumuremyi, et al.. (2017). Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda. BMC Infectious Diseases. 17(1). 315–315. 36 indexed citations

14.

Hill, Andrew, et al.. (2016). Significant Reductions in Costs of Generic Production of Sofosbuvir and Daclatasvir for Hepatitis C Treatment in Low- and Middle-Income Countries. Journal of Hepatology. 64(2). S746–S746. 1 indexed citations

15.

Simmons, Bryony, et al.. (2015). Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response. Clinical Infectious Diseases. 61(5). 730–740. 185 indexed citations

16.

Hill, Alison L., Saye Khoo, Joseph Fortunak, Bryony Simmons, & Nathan Ford. (2014). Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries. Clinical Infectious Diseases. 58(7). 928–936. 157 indexed citations

17.

Roberts‐Thomson, Kaye, Gary D. Slade, Ross Bailie, et al.. (2010). A comprehensive approach to health promotion for the reduction of dental caries in remote Indigenous Australian children: A clustered randomised controlled trial. International Dental Journal. 60(3). 245–249. 37 indexed citations

18.

Kritchevsky, Stephen B., et al.. (1999). Definition and adjustment of Cesarean section rates and assessments of hospital performance. International Journal for Quality in Health Care. 11(4). 283–291. 20 indexed citations

19.

Schwartz, J, Peter M. Waters, & Bryony Simmons. (1993). Endoscopic carpal tunnel release: A cadaveric study. Arthroscopy The Journal of Arthroscopic and Related Surgery. 9(2). 209–213. 38 indexed citations

20.

Simmons, Bryony & Jeffery R. Hughey. (1989). Ehrlichia in Tennessee. Southern Medical Journal. 82(5). 669–669. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact